Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11279-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11279-1-AP, RRID:AB_2171319
- Product name
- PRMT1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PRMT1 antibody (Cat. #11279-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: FC, IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer.
PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.
Cingulate protein arginine methyltransferases 1 regulates peripheral hypersensitivity via fragile X messenger ribonucleoprotein.
The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer.
Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners.
PRMT1 orchestrates with SAMTOR to govern mTORC1 methionine sensing via Arg-methylation of NPRL2.
PRMT4 Facilitates White Adipose Tissue Browning and Thermogenesis by Methylating PPARγ.
Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5.
PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis.
PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
Nguyen CDK, Colón-Emeric BA, Murakami S, Shujath MNY, Yi C
Cell reports 2024 May 28;43(5):114176
Cell reports 2024 May 28;43(5):114176
PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis.
Liu H, Chen X, Wang P, Chen M, Deng C, Qian X, Bai J, Li Z, Yu X
Cell death & disease 2024 Feb 24;15(2):170
Cell death & disease 2024 Feb 24;15(2):170
Cingulate protein arginine methyltransferases 1 regulates peripheral hypersensitivity via fragile X messenger ribonucleoprotein.
Wu C, Shang HF, Wang YJ, Wang JH, Zuo ZX, Lian YN, Liu L, Zhang C, Li XY
Frontiers in molecular neuroscience 2023;16:1153870
Frontiers in molecular neuroscience 2023;16:1153870
The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer.
Zeng X, Yao B, Liu J, Gong GW, Liu M, Li J, Pan HF, Li Q, Yang D, Lu P, Wu D, Xu P, Chen B, Chen P, Zhang M, Zen K, Jing J, Huang DCS, Chen D, Jiang ZW, Zhao Q
NPJ precision oncology 2023 Mar 15;7(1):28
NPJ precision oncology 2023 Mar 15;7(1):28
Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners.
Li Q, Zhang L, Yang Q, Li M, Pan X, Xu J, Zhong C, Yao F, Zhang R, Zhou S, Dai X, Shi X, Dai Y, Xu J, Cheng X, Xiao W, She Z, Wang K, Qian X, Pu L, Zhang P, Wang X
Cell metabolism 2023 Jun 6;35(6):912-927.e7
Cell metabolism 2023 Jun 6;35(6):912-927.e7
PRMT1 orchestrates with SAMTOR to govern mTORC1 methionine sensing via Arg-methylation of NPRL2.
Jiang C, Liu J, He S, Xu W, Huang R, Pan W, Li X, Dai X, Guo J, Zhang T, Inuzuka H, Wang P, Asara JM, Xiao J, Wei W
Cell metabolism 2023 Dec 5;35(12):2183-2199.e7
Cell metabolism 2023 Dec 5;35(12):2183-2199.e7
PRMT4 Facilitates White Adipose Tissue Browning and Thermogenesis by Methylating PPARγ.
Zhong Y, Wang Y, Li X, Qin H, Yan S, Rao C, Fan D, Liu D, Deng F, Miao Y, Yang L, Huang K
Diabetes 2023 Aug 1;72(8):1095-1111
Diabetes 2023 Aug 1;72(8):1095-1111
Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5.
Tian Y, Yang W, Yang R, Zhang Q, Hao L, Bian E, Yang Y, Huang X, Wu Y, Zhang B
Toxicology and applied pharmacology 2022 Jan 15;435:115829
Toxicology and applied pharmacology 2022 Jan 15;435:115829
PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis.
Li Z, Wang D, Chen X, Wang W, Wang P, Hou P, Li M, Chu S, Qiao S, Zheng J, Bai J
Cell death & disease 2021 Nov 13;12(11):1080
Cell death & disease 2021 Nov 13;12(11):1080
PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
Yin XK, Wang YL, Wang F, Feng WX, Bai SM, Zhao WW, Feng LL, Wei MB, Qin CL, Wang F, Chen ZL, Yi HJ, Huang Y, Xie PY, Kim T, Wang YN, Hou JW, Li CW, Liu Q, Fan XJ, Hung MC, Wan XB
Oncogene 2021 Feb;40(7):1375-1389
Oncogene 2021 Feb;40(7):1375-1389
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PRMT1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PRMT1. This antibody recognizes human, mouse, rat antigen. The PRMT1 antibody has been validated for the following applications: ELISA, IHC analysis.